8-Hydroxy-2-deoxy-guanosine identifies oxidative DNA damage in a rural prediabetes cohort

Abstract Background: Rising levels of oxidative stress play an important role in the pathogenesis of type 2 diabetes mellitus. Therefore, we investigated the serum level of 8-hydroxy-2-deoxy-guanosine (8-OHdG) as an early oxidative stress marker in patients with prediabetes and with type 2 diabetes mellitus. Subjects and methods: Convenience sampling from people attending a diabetes screening clinic. Participants at the rural diabetes screening clinic had their medical history recorded as well as body mass index, blood glucose, cholesterol, glutathione, malondialdehyde, fasting blood glucose and 8-OHdG measured. Statistical analysis was performed using ANOVA followed by Sheffe posthoc test for between-group differences. Results: The 8-OHdG level was significantly greater in the prediabetes (516.5 ± 260 pg/ml) compared to control group (177.8 ± 91 pg/ml; P < 0.01). The diabetes group (1926.9 ± 1197 pg/ml) had the highest level of 8-OHdG, being approximately four times greater compared to the prediabetes group (P < 0.001). No significant change in the cholesterol profile, MDA level indicative of lipid peroxidation and antioxidant activity as measured by erythrocyte reduced glutathione was observed in the prediabetes group compared to the control group (P > 0.05). Conclusions: 8-OHdG levels in both the prediabetes and diabetes group were increased from control values suggesting a role for 8-OHdG as an early disease marker that may be more sensitive compared to cholesterol, MDA and erythrocyte reduced glutathione levels, which were within normal limits. This is of clinical significance as 8-OHdG is a strong indicator of oxidative stress related DNA damage within blood vessel walls and other tissue that increases the risk of cardiovascular disease.

[1]  M. Chung,et al.  Effects of 7,8‐dihydro‐8‐oxo‐deoxyguanosine on antigen challenge in ovalbumin‐sensitized mice may be mediated by suppression of Rac , 2009, British journal of pharmacology.

[2]  N. Akhtar Is homocysteine a risk factor for atherothrombotic cardiovascular disease? , 2007, Journal of the American College of Cardiology.

[3]  J. Baynes,et al.  Role of oxidative stress in diabetic complications: a new perspective on an old paradigm. , 1999, Diabetes.

[4]  J. Mehta,et al.  Oxidative stress in diabetes: a mechanistic overview of its effects on atherogenesis and myocardial dysfunction. , 2006, The international journal of biochemistry & cell biology.

[5]  M. Goligorsky,et al.  Oxidative and nitrosative stress in acute renal ischemia. , 2001, American journal of physiology. Renal physiology.

[6]  C. Livingstone,et al.  Review: Targeting therapeutics against glutathione depletion in diabetes and its complications , 2007 .

[7]  M. Hanefeld,et al.  In vivo evidence for increased oxidation of circulating LDL in impaired glucose tolerance. , 2002, Diabetes.

[8]  S. Tagami,et al.  Weakened cellular scavenging activity against oxidative stress in diabetes mellitus: regulation of glutathione synthesis and efflux , 1995, Diabetologia.

[9]  E. Ford,et al.  Is nondiabetic hyperglycemia a risk factor for cardiovascular disease? A meta-analysis of prospective studies. , 2004, Archives of internal medicine.

[10]  J. Stocks,et al.  The Autoxidation of Human Red Cell Lipids Induced by Hydrogen Peroxide , 1971, British journal of haematology.

[11]  E. Beutler,et al.  Improved method for the determination of blood glutathione. , 1963, The Journal of laboratory and clinical medicine.

[12]  M. Chung,et al.  8‐Oxoguanine induces intramolecular DNA damage but free 8‐oxoguanine protects intermolecular DNA from oxidative stress , 2004, FEBS letters.

[13]  T. Tanriverdi,et al.  Relationship between DNA damage and total antioxidant capacity in patients with glioblastoma multiforme. , 2007, Clinical oncology (Royal College of Radiologists (Great Britain)).

[14]  P. O S I T I O N S T A T E M E N T,et al.  Diagnosis and Classification of Diabetes Mellitus , 2011, Diabetes Care.

[15]  H. Jelinek,et al.  Erythrocyte oxidative stress in clinical management of diabetes and its cardiovascular complication : A review , 2008 .

[16]  L. Mohorović The level of maternal methemoglobin during pregnancy in an air-polluted environment. , 2003, Environmental health perspectives.

[17]  Y. Hinokio,et al.  Oxidative damage to mitochondrial DNA and its relationship to diabetic complications. , 1999, Diabetes research and clinical practice.

[18]  P. Hochstein,et al.  The nature of oxidants and antioxidant systems in the inhibition of mutation and cancer. , 1988, Mutation research.

[19]  S. Nitter‐Hauge,et al.  Fasting blood glucose: an underestimated risk factor for cardiovascular death. Results from a 22-year follow-up of healthy nondiabetic men. , 1999, Diabetes care.

[20]  L. Giovannelli,et al.  Oxidative DNA damage and plasma antioxidant capacity in type 2 diabetic patients with good and poor glycaemic control. , 2008, Mutation research.

[21]  D. Daleke,et al.  The role of oxidative stress in diabetic complications , 2007, Cell Biochemistry and Biophysics.

[22]  G. King,et al.  Molecular understanding of hyperglycemia's adverse effects for diabetic complications. , 2002, JAMA.

[23]  P. Zimmet,et al.  Diagnosis and classification of diabetes mellitus , 2002 .

[24]  K. Evelyn,et al.  MICRODETERMINATION OF OXYHEMOGLOBIN, METHEMOGLOBIN, AND SULFHEMOGLOBIN IN A SINGLE SAMPLE OF BLOOD , 1938 .

[25]  O. H. Lowry,et al.  EFFECT OF ISCHEMIA ON KNOWN SUBSTRATES AND COFACTORS OF THE GLYCOLYTIC PATHWAY IN BRAIN. , 1964, The Journal of biological chemistry.

[26]  H. İlkova,et al.  Effect of oxidative stress on glutathione pathway in red blood cells from patients with insulin-dependent diabetes mellitus. , 2002, Metabolism: clinical and experimental.

[27]  Y. Hinokio,et al.  Urinary excretion of 8-oxo-7, 8-dihydro-2′-deoxyguanosine as a predictor of the development of diabetic nephropathy , 2002, Diabetologia.

[28]  S. Loft,et al.  Cancer risk and oxidative DNA damage in man , 1997, Journal of Molecular Medicine.

[29]  M. Laker,et al.  7-ketocholesterol, a specific indicator of lipoprotein oxidation, and malondialdehyde in non-insulin dependent diabetes and peripheral vascular disease. , 1997, Clinica chimica acta; international journal of clinical chemistry.

[30]  J. Keaney,et al.  Role of oxidative modifications in atherosclerosis. , 2004, Physiological reviews.

[31]  K. Woo,et al.  Hyperhomocyst(e)inemia is a risk factor for arterial endothelial dysfunction in humans. , 1997, Circulation.

[32]  H. You,et al.  Anti-inflammatory effects of 8-hydroxy-2'-deoxyguanosine on lipopolysaccharide-induced inflammation via Rac suppression in Balb/c mice. , 2007, Free radical biology & medicine.

[33]  H. Jelinek,et al.  Changes in the erythrocyte glutathione concentration in the course of diabetes mellitus , 2006, Redox report : communications in free radical research.

[34]  R. DeFronzo,et al.  Insulin resistance and endothelial dysfunction: the road map to cardiovascular diseases , 2006, Diabetes/metabolism research and reviews.

[35]  E. Wright,et al.  Oxidative stress in type 2 diabetes: the role of fasting and postprandial glycaemia , 2006, International journal of clinical practice.

[36]  G. Vercellotti,et al.  Ferriporphyrins and endothelium: a 2-edged sword-promotion of oxidation and induction of cytoprotectants. , 2000, Blood.

[37]  A. Sarasin,et al.  Mutagenicity of a unique 8-oxoguanine in a human Ha-ras sequence in mammalian cells. , 1995, Carcinogenesis.

[38]  J. Nielsen,et al.  Plasma malondialdehyde as biomarker for oxidative stress : reference interval and effects of life-style factors , 1996 .

[39]  H. Jelinek,et al.  Erythrocyte oxidative stress in clinical management of diabetes and its cardiovascular complications , 2007, British journal of biomedical science.

[40]  D. Slatter,et al.  The importance of lipid-derived malondialdehyde in diabetes mellitus , 2000, Diabetologia.

[41]  P. Deedwania,et al.  Diabetes, prediabetes, and cardiovascular risk: shifting the paradigm. , 2005, The American journal of medicine.

[42]  Y. Hinokio,et al.  Oxidative DNA damage in diabetes mellitus: its association with diabetic complications , 1999, Diabetologia.